Variant · Snv
NAA15 NM_057175.5(NAA15):c.538-103G>A
CI-VAR-00200616Explore in graph →NM_057175.5:c.538-103G>AClinVar 1274832 rs116034207
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1274832 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Gastric cancer; Familial cancer of breast; Ovarian serous cystadenocarcinoma; Uterine carcinosarcoma; Thymoma; Acute myeloid leukemia; Uterine corpus endometrial carcinoma | germline | 3 | Jun 20, 2021 | clinvar |